Implications for a general role of LPS-binding proteins (CD14,LBP) in combating bacterial infections

Abstract

An invading pathogen must be held in check by the innate immune system until a specific immune response can be mounted. In the case of Gram-negative bacteria, the principal stimulator is LPS, a component of the outer membrane of the bacteria. In vitro LPS is bound by LBP and transferred to the LPS receptor CD14 on the macrophage surface. Binding to CD14 triggers an inflammatory response which is crucial for keeping an infection under control. In vitro, LBP mediates a response not only to LPS but also to intact Gram-negative bacteria. We show that whole Escherichia coli bacteria are recognised by CD14 on human monocytes, and subsequently may become phagocytosed. Although neither LBP nor CD14 interact with the heat inactivated, intact Gram-positive bacterium Bacillus subtilis both proteins form stable complexes with lipoteichoic acid derived from the bacterial cell wall. A brief exposure of B. subtilis to serum or antibiotics converts them into a form which can be recognised by CD14 in an LBP-dependent manner followed by phagocytosis. In preliminary experiments, it is shown that LBP is essential in vitro for the oxidative burst response of mouse macrophages induced by living Salmonella typhimurium as well as Staphylococcus epidermidis. Our results indicate that, in addition to CD14, LBP is also a pattern recognition element and is required to induce a rapid inflammatory response to Gram-negative as well as to Gram-positive bacteria and to initiate their phagocytosis.

References

Rietschel ET , Kirikae T. , Schade RU et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217—225.

Wright SD , Ramos RA , Tobias PS , Ulevitch RJ , Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431—1433.

Schumann RR , Leong SR , Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science 1990; 249: 1429—1431.

Pugin J. , Heumann D. , Tomasz A. et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509—516.

Soell M. , Lett E. , Holveck F. , Schöller M. , Wachsmann D. , Klein JP Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits. J Immunol 1995; 154: 851—860.

Newman SL. Chaturvedi S. , Klein BS The WI-1 antigen of Blastomyces dermatidis yeast mediates binding to human macrophage CD11b/CD18 (CD3) and CD14. J Immunol 1995; 154: 753—761.

Espevik T. , Otterlei M. , Skyak-Break G. , Ryan L. , Wright SD , Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 1993; 23: 255—261.

Jack RS , Grunwald U. , Stelter F. , Workalemahu G. , Schütt C. Both membrane-bound and soluble forms of CD14 bind to Gram-negative bacteria . Eur J Immunol 1995; 25: 1436—1441.

Grunwald U. , Fan X. , Jack RS et al. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J Immunol 1996; 157: 4119—4125.

10.

Stelter F. , Bernheiden M. , Menzel R. et al. Mutation of amino acids 39—44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem 1997; 243: 100—109.

11.

Jack RS , Fan X. , Bernheiden M. et al. Lipopolysaccharide binding protein is required to combat a murine Gram-negative bacterial infection. Nature 1997; 389: 742—745.

12.

Schütt C. , Schilling T. , Grunwald U. , Schönfeld W. , Krüger C. Endotoxin neutralizing capacity of soluble CD14. Res Immunol 1992; 143: 71—78.

13.

Schiff DE , Kline L. , Soldau K. et al. Phagocytosis of Gram-negative bacteria by a unique CD14-dependent mechanism. J Leukoc Biol 1997; 62: 786—794.

14.

Onozuka K. , Kirikae T. , Kirikae F. et al. Participation of CD14 in the phagocytosis of smooth-Type Salmonella typhimurium by the macrophage-like cell line, J774.1. Microbiol Immunol 1997; 41: 765—772.

15.

Yu B. , Hailman E. , Wright SD Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids . J Clin Invest 1997; 99: 315—324.

16.

Devitt A. , Moffatt OD , Raykundalia C. , Capra JD , Simmons DL , Gregory CD Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392: 505—509.

17.

Savill J. Phagocytic docking without shocking. Nature 1998; 392: 442—443.

18.

Fadok VA , Bratton DL , Konowal A. , Freed PW , Westcott JY , Henson PM Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890—898.